Skip to main content

Posts

Showing posts with the label journals

Cerebral Microbleeds and Antithrombotic Treatments—Stop Worrying About Bleeding

Cerebral microbleeds (CMBs) are found in up to one-third of patients with ischemic stroke. Because of their hemorrhagic histopathological substrate, they have been historically associated with a risk of intracerebral hemorrhage (ICH). This has led to concerns about the safety of anticoagulation use in patients with CMBs even in the context of high risk of recurrent ischemic stroke, such as in atrial fibrillation. However, growing evidence suggests that CMBs are not only markers of bleeding propensity but also markers of future ischemic events. To further evaluate both types of risks, an assessment of the number and anatomic distribution of CMBs might be helpful. Unfortunately, available data are based on observational studies with inherent bias and, to our knowledge, no randomized clinical trial to date has clearly determined the net clinical benefit of anticoagulation in patients with CMBs and a high risk of thromboembolic events. from journals https://ift.tt/2HmWq2B

Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment

This cross-sectional study used screening data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease Study (A4 Study) to assess whether the presence of the apolipoprotein E ε2 allele is protective against β-amyloid accumulation in the presence of ε4 in individuals without cognitive impairment. from journals https://ift.tt/343Dnmu

Secrets of Creativity

Author: Edited by Suzanne Nalbantian and Paul M. Matthews ISBN: 9780197550816 Binding: Paperback Publication Date: 15 October 2020 Price: $35.00 from journals https://ift.tt/315QvWg

Dementia: A Very Short Introduction

Author: Kathleen Taylor ISBN: 9780198825784 Binding: Paperback Publication Date: 01 October 2020 Price: $11.95 from journals https://ift.tt/3n5nQKl

Resolving Neurodevelopmental and Vision Disorders Using Organoid Single-Cell Multi-omics

In this Perspective, Brancati et al. explain how stem-cell-derived human organoids combined with single-cell genomic phenotyping provide an exciting new inroad to understanding neurodevelopmental and vision disorders and discuss next steps in organoid engineering to address current deficiencies. from journals https://ift.tt/32VMkhl

Artificial Neural Networks for Neuroscientists: A Primer

Artificial neural networks (ANNs) are essential tools in machine learning that have drawn increasing attention in neuroscience. Besides offering powerful techniques for data analysis, ANNs provide a new approach for neuroscientists to build models for complex behaviors, heterogeneous neural activity, and circuit connectivity, as well as to explore optimization in neural systems, in ways that traditional models are not designed for. In this pedagogical Primer, we introduce ANNs and demonstrate how they have been fruitfully deployed to study neuroscientific questions. We first discuss basic concepts and methods of ANNs. Then, with a focus on bringing this mathematical framework closer to neurobiology, we detail how to customize the analysis, structure, and learning of ANNs to better address a wide range of challenges in brain research. To help readers garner hands-on experience, this Primer is accompanied with tutorial-style code in PyTorch and Jupyter Notebook, covering major topics.

Intensive Blood Pressure Reduction in Intracerebral Hemorrhage With Extreme Initial Hypertension

Among factors associated with functional outcomes after intracerebral hemorrhage (ICH), hematoma growth consistently emerges as the most relevant potentially modifiable risk factor for poor outcomes. Short-term treatment strategies to reduce hematoma growth have pursued 2 pathways: improving hemostasis and reducing extravasation by means of blood pressure reduction. Basic principles of fluid mechanics suggest that a larger pressure gradient across the arteriole wall will increase the likelihood of rerupturing and, in the case of incomplete thrombosis of the ruptured vessel wall, will increase the rate of extravasation. In patients with aneurysmal subarachnoid hemorrhage, in whom vessel rerupture is a more readily ascertained event, studies indicate that higher systolic blood pressure (SBP) is a risk factor for rebleeding. In ICH, the presence of perihematomal contrast extravasation (called the spot sign) indicates ongoing extravasation and is associated with higher blood pressure. Evid

Selective Neuronal Vulnerability in Alzheimer’s Disease: A Modern Holy Grail

In this issue of Neuron, through an elegant progression of computational and bio-informatic experiments centered on transcriptomic comparison of vulnerable and resistant neurons across species, Roussarie et al. (2020) predict and provide experimental support for specific genes and molecular pathways driving Alzheimer’s disease, including the splicing factor PTBP1. from journals https://ift.tt/3kdXMe7